FDA Approves Genzyme Corporation (GENZ)'s Gaucher Disease Pill Cerdelga
Amgen (AMGN), Bristol-Myers Squibb Company (BMY) On The Prowl For Space In Crowded Cambridge, Massachusetts
Good News For Amgen (AMGN) As Parathyroid Drug AMG 416 Succeeds In Phase 3 Study
Redwood City's Dermira Bags $51 Million, Expands Management Team And Board
Bay Area's HealthQuest Capital Bags $110 Million For Debut Fund With Healthcare, Medtech Focus
AstraZeneca PLC (AZN) Says U.S. Authorities End Probe Into Clinical Trial Of Star Heart Drug Brilinta
Allergan Inc. (AGN) CFO Steps Down In Midst Of Hostile Takeover Bid By Valeant Pharmaceuticals International (VRX)
Eli Lilly and Company (LLY)-Tied Church Sues Chase Over Mismanaged Trust
Confirmed: Novartis AG (NVS) To Invest In Gamida Cell Ltd., Could Buy Out Company In $635 Million Cancer Deal
FDA Tentatively Approves Boehringer Ingelheim Corporation, Eli Lilly and Company (LLY)'s Basaglar™
Sweden's Recipharm AB Pays $160 Million For Corvette Pharmaceutical Services Group
Baxter International, Inc. (BAX) Recalls Dialysis Solution Over Contamination Concerns
San Diego Startup, Batu Biologics, Achieves Goal In Crowdfunding Campaign
iCo Therapeutics Inc. Announces Positive Oral Amphotericin B Study Results
Actavis (ACT) Reports Positive Top-Line Data From Two Ceftazidime-Avibactam Late-Stage Trials
MediciNova, Inc. Shows Off Positive Phase 2a Study Of Ibudilast
Biomedical Advanced Research and Development Authority (BARDA) Extends Contract With Cytori Therapeutics, Inc. (CYTX) For Burn Treatment, Deal Is Worth Up To $20.4 Million
Sanford-Burnham Medical Research Institute Appoints Perry Nisen As Chief Executive Officer
See All News >
Best Biotech Employers In America
Cubist Pharmaceuticals, Inc. (CBST) Could Be An Acquisition Target For Needy Pfizer Inc. (PFE)
Silicon Valley’s Hottest Tech Accelerator, Y Combinator, To Debut Biotech Startups
Gilead Sciences, Inc. (GILD) Shaky As Achillion Pharmaceuticals, Inc. (ACHN)'s Hepatitis C Drug Cures All Patients In Mid-Stage Trial
FDA Approves Biogen Idec, Inc. (Massachusetts) (BIIB)'s Multiple Sclerosis Drug Plegridy
Pfizer Inc. (PFE) Is Liable For Harm Caused By A Generic Rival: Court
Deal Is Back On: Novartis AG (NVS) To Invest Heavily In Gamida Cell Ltd. Before Acquisition
Conflicting Reports Surface Over Roche Holding AG (RHHBF.PK)'s $10 Billion Deal, Chugai Pharmaceutical Co., Ltd. (Japan) Denies Talks
Abbott Laboratories (ABT) Strikes $20 Million Pentagon Deal For Brain Injury Device
You Are What You Eat: 6 Smelly Foods That Are Actually Giving You Bad Body Odor
Eisai Company, Ltd. (ESALY.PK) Sues The FDA To Regain "Lost" Marketing Time For Its Drugs
Pharmaceutical Industry Blamed For Robin Williams' Death
Redwood City's Comprehend Systems Bags $21 Million Series B Funding
InterMune, Inc. (ITMN) Goes Up On The Block; GlaxoSmithKline (GSK), Roche (RHHBY), Sanofi (France) (SAN.PA) Line Up
Incyte Corporation (INCY), Novartis AG (NVS)’ New Drug Helps Some Bald Patients Regrow Hair
Ampio Pharmaceuticals, Inc. (AMPE) Touts Very Positive Data For Ampion Osteoarthrtis Study
Apathy Sends Biotech Jobs Offshore, Says CSL Limited (CMXHF.PK)
Teen’s Organs Rejected Because He’s Gay
See All News >
//-->